Series – Page 4 – media

Cambridge’s Exonics Therapeutics Scores $40M

Exonics Therapeutics closed on a $40 million Series A financing. It was led by The Column Group.
- Source: biospace
- 118
- December 7, 2017
DMD Market Views neuromuscular Series
Astellas Takes Out Massachusetts’ Biotech Mitobridge in $390M Deal

Tokyo-based Astellas Pharma is buying Cambridge, Mass.-based Mitobridge for a total of $390 million. Astellas is pulling the trigger on an acquisition option from a partnership deal the two companies formed in 2013. Under that deal, the two companies collaborated on discovering and developing drugs that target mitochondrial function. The most advanced program from the collaboration is MA-0211, which is presently in Phase I clinical trials for Duchenne muscular dystrophy (DMD). Astellas is an equity investor in Mitobridge already, and is paying $165.5 million in cash in addition to the $60 million in equity it already owns. There is also an additional $225 million in potential milestone payments. John Carroll, with Endpoints News, writes, “For years now, Salk’s Ron Evans—a celebrated serial entrepreneur in scientific circles—has been concentrating on the potential of a new pathway for turning your average couch potato rodent into Mighty Mouse—without exercise…. A couple of ...
- Source: biospace
- 148
- December 5, 2017
acquisition Astellas Clinical Trials Duchenne muscular dystrophy Market Views Series
Codiak BioSciences Closes $76.5 Million Series C Financing

Codiak intends to use the proceeds of the Series C financing to advance its initial product candidates into clinical trials, and to continue to develop the company's transformational exosome therapeutic platform.
- Source: Businessinsider
- 154
- November 30, 2017
Clinical Trials exosome therapeutic Market Views Series
Doctolib raises another $42 million for its medical care scheduling service

French startup Doctolib is raising money for the second time in the past twelve months. The company is building a sort of Salesforce for the healthcare industry with a big emphasis on bookings. Doctolib just raised $42 million (€35 million) from Eurazeo and existing investor Bpifrance.
- Source: Technologythrill
- 105
- November 29, 2017
Doctolib Market Views Series
Bay Area’s Medeor Therapeutics Bags $57M

Medeor Therapeutics announced it had closed on an oversubscribed Series B financing worth $57 million. The round was led by RA Capital Management. New investors included Sofinnova Ventures and 6 Dimensions Capital. They were joined by existing investors Vivo Capital and WuXi Healthcare Ventures.
- Source: Biospace
- 190
- November 28, 2017
cellular immunotherapies Market Views Series
Amgen makes regenerative medicine play, backing $25M Fortuna round to move neural stem cells into the clinic

Amgen’s VC wing has invested in Fortuna Fix to help move autologous neural stem cells into the clinic. The $25 million series B sets regenerative medicine startup Fortuna up to move candidates against Parkinson’s disease and spinal cord injury to clinical trials next year.
- Source: Fiercebiotech
- 100
- November 14, 2017
Amgen autologous neural stem cells Series
Genetic testing startup Prenetics raised $40M in Series B round led by Alibaba’s Hong Kong fund and Beyond Ventures

Genetic testing startup Prenetics has raised $40 million in a Series B funding round led by Hong Kong-based venture capital fund Beyond Ventures and the Alibaba Hong Kong Entrepreneurs Fund.
- Source: Mastsea
- 200
- October 19, 2017
Artificial Intelligence Market Views Series
Medical Monitoring Device Maker MagicMed Bags USD1.5 Million in Pre-Series A Financing

Medical equipment maker MagicMed Technologies (Beijing) Co. has secured USD1.5 million (CNY10 million) in pre-series A financing. The funds will help the firm hasten the commercialization of its Magitor Cell, a single channel electrocardiographic monitoring device.
- Source: Yicaiglobal
- 123
- October 18, 2017
MagicMed Technologies Magitor Cell Series
InflaRx announces a $ 55M Series D financing and investment round

InflaRx, the biopharmaceutical company developing new therapeutics in the terminal complement space, announced a $ 55M Series D financing and investment round.
- Source: inflarx.de
- 176
- October 17, 2017
Market Views Series therapeutics
Cardiologs raises $6m in Series A to support ECG Analysis Platform

Cardiologs Technologies said this week it raised $6.4 million in a Series A round of financing to support accelerated commercialization of its Cardiologs ECG Analysis Platform in the US and Europe.
- Source: Massdevice
- 130
- October 10, 2017
Cardiologs Market Views Series

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

Exhibitions & Activitiesmore

Ddu to Attend CPhI in Shanghai Sharing Insights on International Marketing of the Medical Trade

June 19, 2018
IRANPHARMA EXPO 2018

June 14, 2018
Drugdu.com Launches Digital Marketing Strategy Solution for Pharmaceuticals and Medical Devices at CMEF Shanghai 2018

May 8, 2018
Ddu Attended CPhI North America Great Success with the “Internet + Cross-border medical trade” Marketing Model

May 3, 2018
Ddu’s International Medical Exhibition Attendance Delivering High Results.

April 9, 2018

Market Reportsmore

China’s Import and Export Market Report of Diabetes Drugs

May 4, 2018
China’s Import and Export Market Report of Vitamins

April 11, 2018
China’s Import and Export Market Report of Contraceptive Drugs

March 16, 2018
Ddu College — China’s Import and Export Report of Peptic Ulcer Drugs

January 25, 2018
China’s Import and Export Report of External Use Otology Drugs

January 12, 2018

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.